Cargando…
S100A6 inhibits MDM2 to suppress breast cancer growth and enhance sensitivity to chemotherapy
BACKGROUND: S100A6 and murine double minute 2 (MDM2) are important cancer-related molecules. A previous study identified an interaction between S100A6 and MDM2 by size exclusion chromatography and surface plasmon resonance experiments. The present study investigated whether S100A6 could bind to MDM2...
Autores principales: | Qi, Mengxin, Yi, Xianglan, Yue, Baohui, Huang, Mingxiang, Zhou, Sheng, Xiong, Jing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10204293/ https://www.ncbi.nlm.nih.gov/pubmed/37217945 http://dx.doi.org/10.1186/s13058-023-01657-w |
Ejemplares similares
-
Honokiol Inhibits HIF-1α-Mediated Glycolysis to Halt Breast Cancer Growth
por: Yi, Xianglan, et al.
Publicado: (2022) -
FKBP12 enhances sensitivity to chemotherapy-induced cancer cell apoptosis by inhibiting MDM2
por: Liu, T, et al.
Publicado: (2017) -
Rapamycin Inhibits IGF-1-Mediated Up-Regulation of MDM2 and Sensitizes Cancer Cells to Chemotherapy
por: Du, Wei, et al.
Publicado: (2013) -
Correction: Rapamycin Inhibits IGF-1-Mediated Up-Regulation of MDM2 and Sensitizes Cancer Cells to Chemotherapy
por: Du, Wei, et al.
Publicado: (2013) -
Hinokiflavone Inhibits MDM2 Activity by Targeting the MDM2-MDMX RING Domain
por: Ilic, Viktoria K., et al.
Publicado: (2022)